MENU
+Compare
TARA
Stock ticker: NASDAQ
AS OF
Sep 5, 04:59 PM (EDT)
Price
$3.15
Change
-$0.02 (-0.63%)
Capitalization
121.53M

TARA Protara Therapeutics Forecast, Technical & Fundamental Analysis

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases... Show more

TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TARA with price predictions
Sep 04, 2025

TARA in upward trend: 10-day moving average moved above 50-day moving average on August 14, 2025

The 10-day moving average for TARA crossed bullishly above the 50-day moving average on August 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where TARA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on TARA as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TARA just turned positive on August 27, 2025. Looking at past instances where TARA's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

TARA moved above its 50-day moving average on August 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TARA advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TARA entered a downward trend on August 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.842) is normal, around the industry mean (20.013). P/E Ratio (0.000) is within average values for comparable stocks, (51.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.122). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (326.881).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TARA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TARA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TARA is expected to report earnings to rise 7.86% to -37 cents per share on October 30

Protara Therapeutics TARA Stock Earnings Reports
Q3'25
Est.
$-0.38
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 101.53K shares outstanding, the current market capitalization sits at 121.53M.
A.I. Advisor
published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRQF0.980.04
+4.17%
AMAROQ LTD.
SONVY59.011.07
+1.85%
Sonova Holding AG
TCVNF0.660.01
+1.80%
Tocvan Ventures Corp.
SPSAF221.00N/A
N/A
SOPRA SA
DOSEF1.00N/A
N/A
Doseology Sciences Inc.

TARA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with BRNS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-1.86%
BRNS - TARA
34%
Loosely correlated
+4.72%
ITRM - TARA
31%
Poorly correlated
+0.48%
CDIO - TARA
31%
Poorly correlated
-5.19%
SQZB - TARA
30%
Poorly correlated
N/A
RNXT - TARA
30%
Poorly correlated
-4.80%
More